Since the introduction of nucleic acid testing (NAT) for routine blood donor screening, hepatitis C virus (HCV) RNA-only detection rates reported from Poland have been higher than in most other European countries.
STUDY DESIGN AND METHODS:
To examine factors that likely contribute to these window-period donations, we conducted a case-control study among 47 recently HCV-infected blood donors (cases), who gave blood between July 2002 and June 2014, and 141 controls matched by age, sex, and donation dates. Firthcorrected, conditional logistic regression models were fitted to estimate adjusted odds ratios and 95% confidence intervals. Adjusted population-attributable fractions were calculated based on the distribution of exposure among the cases.
RESULTS:
On multivariate analysis, recent exposures in health care environments not routinely ascertained through predonation questionnaires were strongly associated with recently acquired HCV infection. These exposures included minor medical and dental procedures in the preceding 6 months (adjusted odds ratio, 5.77; 95 % confidence interval, 2.01-18.53). However, based on the population-attributable fraction, more important were behavioral deferrable risks that went unreported at the time of donation, such as high-risk sexual behaviors in the preceding 6 months (population-attributable fraction, 34%) or lifetime histories of drug use (population-attributable fraction, 28%).
CONCLUSIONS:
This study raises questions about the effectiveness of deferral policy in excluding high-risk individuals. In addition, it provides further evidence supporting short, temporal deferrals for small medical procedures and dental treatments in Poland. R outine screening of blood donations for hepatitis C virus (HCV) RNA by nucleic acid testing (NAT) has been introduced in most European countries and elsewhere to reinforce the safety of the blood supply. NAT can identify an early phase of HCV infection, when antibodies are undetectable. 1 the first appearance of detectable antibodies is 8 or 9 weeks. 2, 3 Therefore, it can be presumed that HCV RNApositive blood donors with no detectable HCV antibodies have very recently been infected. Poland was one of the first countries to introduce NAT for blood donor screening. Molecular biology was implemented in 1999 for HCV RNA screening in plasma for fractionation and in 2002 for all blood donors. 4 Although all donors in Poland are voluntary and nonremunerated, undergo medical assessment, and deny risk factors for viral infections before donation, the frequency of serologic window-period (WP) donations is much higher than in other European countries. Busch and colleagues, who compared the rates of HCV NAT-onlypositive donations between countries, reported that, since the implementation of HCV NAT screening through 2008, the highest number of HCV WP infections among participating European countries was noted in Poland, with 83 out of a total 181 infections. 5 Despite a recent downward trend, the HCV NAT-only detection rate in Poland remains higher than elsewhere in Europe along with the residual risk of transfusion-transmitted infection. 6, 7 The rate of HCV NAT-only-positive donations depends on the combination of the incidence in the population from which the candidates are recruited and the effectiveness of deferring high-risk individuals. The deferral criteria currently in place cover the major blood-borne infections' risk factors described in the general population in Poland. These include behavioral factors (history of injecting drug use, high-risk sexual behaviors), which should lead to self-deferral of a candidate, as well as medical factors, such as a history of major surgical procedures ascertained through predonation questionnaire. The deferral of high-risk individuals can be compromised if the deferral criteria do not match the epidemic pattern in the country and fail to exclude a high-incidence group. In Poland, it is believed that HCV is transmitted mainly through medical procedures. Before blood screening for HCV became available, blood transfusion was a leading means of HCV transmission. Recently, most newly diagnosed, presumably health care-associated infections have been linked with invasive procedures performed in the past. This could be explained by delayed introduction of safety procedures in medical settings and common human errors. 8, 9 Although invasive medical procedures appear to be a significant risk factor among the general population in Poland, people who inject drugs may be the most affected population group, [9] [10] [11] and this is reflected in the adopted criteria. However, even a well-evidenced deferral strategy will fail in the case of noncompliance with the criteria. Indeed, some donors may present to the blood donation center precisely because of their risky behavior, in order to obtain free, good-quality testing. [12] [13] [14] [15] By recognizing the factors associated with newly acquired HCV infection, we aimed to clarify whether the high rate of HCV WP donations in Poland might be attributed to insufficient compliance with existing criteria or to other factors associated with increased incidence in populations that are not currently considered for deferral.
MATERIALS AND METHODS

Ethics statement
This study relies on surveillance data collected during donors' postdonation risk-exposure assessments, which were carried out by Regional Blood Transfusion Centers between July 2002 and June 2014 in accordance with Polish Medical Regulations for the collection, preparation, and distribution of blood and blood components.
During predonation counselling, medical staff at the centers ensures that prospective donors clearly understand the nature of the donation process and the associated risks along with their right to withdraw consent at any stage of the procedure. At this point, written informed consent to the blood donation procedure, including assessment of the donor's health and risk factors, is obtained. Prospective donors also consent to follow-up contact from the donation center after the test results are made available. In the case of inconclusive or positive results in any of the blood tests, the centers make three attempts (by post) to contact the donor and schedule a follow-up visit. During the follow-up visit, confirmatory testing is offered, as appropriate. In addition, the patients are invited to take part in an extended surveillance survey for postdonation risk-exposure assessment. Negative results are only released on request.
Blood donation eligibility requirements
Polish blood donors are voluntary and nonremunerated. There are more than 150 blood donation collection sites (21 regional blood centers with over 130 local collection sites), which carry out 1.2 million blood donations annually and provide blood supply to more than 600 hospitals. 16, 17 All blood donation collection sites in Poland use uniform guidelines for the assessment of blood donor eligibility. 18 The donor deferral policy in place is expected to effectively reduce the number of infections detected through self-deferral of prospective donors if they are aware of having been exposed to any risk of blood-borne pathogens, such as HCV, hepatitis B virus (HBV), human immunodeficiency virus (HIV), and syphilis, after reviewing the donor educational brochures. The main prerequisite for self-deferral is a history of injecting drug use and risky sexual behavior, such as sexual contact with an injecting drug user, an individual with HIV or hepatitis, contact with a new partner, or more than one partner in the preceding 6 months. Before donation, prospective donors are screened for high-risk activities through a predonation, paper-based questionnaire administered by a clinician. A brief physical examination is also performed. This procedure helps the donor center's physicians to determine whether the candidate is suitable for donating blood. Based on this evaluation, prospective donors can be temporarily or permanently deferred from donating their blood. We note that blood donors in Poland are predominantly males. During 2005 through 2015, male donors constituted approximately 75% of the total blood donor population (unpublished data, Institute of Hematology and Transfusion Medicine, Warsaw).
Blood testing algorithm
The testing algorithm used in routine screening and its evolution over time has been described in detail elsewhere. 19 Briefly, blood donor screening for HCV viral markers in Poland is currently based on serologic testing for anti-HCV, and NAT for RNA HCV. It is conducted in minipools of six, with real-time polymerase chain reaction (MPX 2.0 test on the cobas s201; Roche), or transcriptionmediated amplification in individual donations (Ultrio Plus or Ultrio Elite; Grifols). In cases of repeat reactive results, the donor plasma is tested in a separate sample from the NAT yield donation and in follow-up samples.
Study design
We followed a case-control study design. A case was defined as a person who had evidence of a recently acquired HCV infection. Recently acquired infections were defined as the detection of HCV RNA with negative HCV antibodies (WP) or documented HCV antibody seroconversion over the last 12 months. The WP is the most accurate indicator of recent HCV infection, but it is uncommon. Therefore, we also considered recently acquired infections with the documented seroconversion of donors who repeatedly donate blood. The postdonation survey was administered in a face-to-face interview with the transfusion center physician at the time of the follow-up visit, which was arranged for the collection of blood samples to confirm HCV status. Controls were recruited from the donors who were negative for all screened infection markers. The standard procedure was to invite (as controls) two consecutive donors seen after a patient who was positive for any of the early markers of HIV, HCV, or HBV infection. 18 No matching was performed at the time of enrolment. The postdonation survey questionnaire was developed based on a questionnaire specifically designed for sentinel surveillance of acute viral hepatitis in the United States. 20 It includes closed-end questions about the donors' characteristics, health conditions, and other risk factors along with a broad list of recent exposures that could explain their acquisition of an infection up to 6 months before diagnosis. We also asked respondents about certain lifetime risk factors, which are not risk behaviors per se but may be useful in defining the most affected subgroup.
The following categories of exposures were assessed: 1) medical exposures (a history of dental procedures, hospitalization, surgical procedures, or other medical procedures, e.g., dialysis, kidney transplantation, transfusion); 2) occupational exposure to blood (health care employment with frequent blood contact, employment in community services); 3) tattoos, body piercings, drug use, and steroid use; 4) sexual risk behaviors and sexual partners (the number of sexual partners, sex with people of the same gender, sex with an individual who has hepatitis or with a drug-using partner, sex with transfusion recipients or surgical patients, a previous history of engaging in sex for money or drugs, and a previous history of sexually transmitted diseases); 5) casual contact within the household (residing with a drug or steroid user, residing with an individual who has hepatitis, sharing razors or toothbrushes); and 6) other factors (including exposure to menstrual blood, involvement in street fights, or a history of arrests or detention).
Statistical analysis
To each individual with evidence of recently acquired HCV infection (case), three HCV NAT-negative and antibody-negative controls were randomly matched without replacement by age (610 years), sex, and donation dates, using a greedy matching algorithm. 21 To account for the matched case-control study design and "sparsedata" bias, we used Firth-corrected conditional logistic regression. 22 Univariate odds ratios (ORs) and 95% confidence intervals (CIs) were calculated in models fitted only for one exposure at a time, with HCV status as an outcome variable. In the presence of zero cell counts, to provide valid estimates of exposure effect, a stratified exact logistic regression was used instead. The multivariate model was built in a stepwise fashion using results from the univariate analysis (p < 0.2). Some of the exposures from 6 months before donation perfectly predicted the dependent variable. For dealing with data separation in the multivariate analysis, we collapsed similar risks into a single factor (i.e., various categories of minor medical procedures or high-risk sexual activities). Newly created predictors were history of minor medical procedures (involving minimally invasive surgery, admission to hospital for diagnosis or treatment of medical conditions without surgery, outpatient procedures, or dental procedures in the preceding 6 months) and history of deferrable sexual risk (sexual behaviors involving two or more sex partners, a drug-using partner, or sex with an individual who had hepatitis in the preceding 6 months that, if reported at the time of donation, would have resulted in deferral). In addition, one problem variable (having been tattooed) was recoded to a capture interval of 12 months instead of 6 months. This allowed us to retain the strongest predictors in the multivariate model.
The adjusted population-attributable fractions (PAF) for predictors that were retained in the multivariate model were calculated using a variation of the Rothman formula for a case-control design based on the distribution of exposure, for which ORs were used as an approximation of risk ratios. The formula is as follows: PAF 5 (number of exposed cases/total cases)/([adjusted OR 2 1]/adjusted OR). Statistical analyses were performed using SAS 9.3.
RESULTS
Sample characteristics
During 2002 through 2014, the annual number of diagnosed HCV NAT-only-positive infections ranged from 1 to 20, with a median of 7 (Fig. 1) . Of the 105 HCV NAT-onlypositive infections identified between 2002 and 2014, 32 cases (30%) were included in the study in addition to 15 (7%) repeat donors out of an estimated 220 donations with documented HCV antibody seroconversion over the last 12 months. More background on the laboratory findings, including genotypes and viral loads of HCV WP infections, can be found elsewhere. 4, 23, 24 Compared with all HCV NAT-only-positive infections identified at the time of the study, the enrolled cases were similar in terms of mean age (29 vs. 28 years; p 5 0.648), the percentage of men (91% vs. 87%; p 5 0.395), and firsttime donation status (15% vs. 23%; p 5 0.261).
Of 200 HCV NAT-negative and antibody-negative controls selected for the study, 141 were randomly matched to cases in 47 sets of three controls for each case. Thus, the studied sample consisted of 47 cases and 141 controls.
Selected controls were the same sex, a similar age, had the same first-time donation status, and gave blood up to 12 months after the identification of cases ( Table 1) .
Predictors of HCV infection
In the univariate analysis, recently acquired HCV infection was most strongly associated with involvement in a street fight (OR, 28.8; 95% CI, 5.6, infinity), sex with a drug-using partner (OR, 24.5; 95% CI, 4.6, infinity), and having been tattooed (OR, 20.2; 95% CI, 3.7, infinity) ( Table 2) . Equally important predictors were living with an individual who had hepatitis (OR, 11.0; 95% CI, 2.2-107.2) and a lifetime history of arrest or detention (OR, 11.4; 95% CI, 3.2-59.6).
Among deferrable sexual risks (sexual behaviors that, if reported at the time of donation, would have resulted in deferral), apart from sex with a drug-using partner, having multiple sex partners of the opposite sex in the past 6 months before donation strongly predicted recently acquired HCV infection (OR, 11.6; 95% CI, 4.0-44.8).
Also in the univariate analysis, recent infection was predicted by a history of deferrable sexual risk combined (OR, 13.3; 95% CI, 4.6-50.9), a history of drug use (OR, 6.8; 95% CI, 2.8-18.3), and a history of minor medical procedures (OR, 2.9; 95% CI, 1.3-6.6).
The final Firth-corrected conditional logistic regression model contained four predictors that were independently associated with HCV acquisition: minor medical procedures or deferrable sexual risk (in the preceding 6 months), tattooing (12 months before donation), and one lifetime risk factor (use of injected/noninjected drugs). Upon multivariate adjustment, the effect size (adjusted OR [AOR]) associated with health care exposures increased almost two times for a history of small medical and dental procedures (AOR, 5.8; 95% CI, 2.0-18.5). The highest adjusted PAF, however, was assigned to deferrable sexual behaviors (34%) and a history of drug use (28%) ( Table 3) .
Of 47 cases, 37 (79%) reported at least one of the risk factors that was retained in the multivariate model. Distribution of these factors varied across age. Medical exposures and high-risk sexual behaviors tended to be more evenly distributed across all ages (median age, 29 years; range, 20-56 years), whereas a history of drug use or tattooing was more predominant in younger age groups (median age, 23 years; range, 19-36 years).
In addition, two cases reported household contact with individuals who had documented hepatitis C or an occupational exposure to blood. The remaining eight cases reported none of the exposures or risk factors that were included in the questionnaire.
DISCUSSION
Our study is one of very few to assess the known and potential risks for HCV at the time approximate to the virus acquisition. In this study, we confirmed that small medical procedures and dental treatments likely contributed to the high rate of recently acquired HCV infections among blood donors in Poland. A significant proportion (26%) of recent infections could be attributed to these exposures. However, we also note that what was even more important was the insufficient deferral of individuals with high-risk behaviors.
In our study, minor medical and dental procedures were strongly associated with recently acquired HCV infection (AOR, 5.8; 95% CI, 2.0-18.5). Medical exposures were consistently associated with HCV infections in Poland. 10, 25, 26 However, previous studies relied on prevalent rather than incident cases, which precluded the drawing of strong conclusions about current transmission patterns. These studies ascertained the lifetime history of exposures, making it very difficult to study the minor medical and dental procedures that are common in the population. Consequently, associations of HCV prevalence were found only with major medical procedures (e.g., frequent hospitalization, surgery 10 ). On the other hand, national surveillance data suggest that HCV transmission also could occur in the context of minor medical exposure in health care environments. Indeed, almost 30% of reported cases of acute hepatitis C are likely associated with small medical procedures, including injections and dental treatments, which are the only identifiable risk factors for infection in the incubation period of the disease. 9 By studying recent infections, we were able to confirm these findings in the low-risk population, suggesting a need for the reiteration of safety principles in medical/ dental clinics.
Currently, in line with the findings from the previous studies, the donor-selection criteria include temporal deferral of individuals with a history of major surgery or other invasive medical procedures. Dental and minor medical procedures are much more common in the population. Approximately 10% of donors from among our control group reported having had these procedures in the 6 months before their donation, making it unfeasible to introduce long-term deferral based on this criterion. However, the inclusion of a short temporal deferral (e.g., 1-2 weeks), matching the WP period for NAT methods for candidates who had had such a procedure, could be considered. We also observed strong associations between several behavioral factors and recently acquired HCV infection. In * Pairs of individuals were matched according to age, sex, and donation date. † These involved: 1) minimally invasive surgery, 2) admission to hospital for diagnosis or treatment of medical condition without surgery, 3) an outpatient procedure, or 4) a dental procedure. ‡ This patient had septoplasty and was admitted to hospital. § Patients were admitted to hospital for the diagnosis or treatment of a medical condition without surgery. k Cases received injections or cervical smears, and controls received stitches or circumcision; all were treated as outpatients.
¶ ORs (95% CIs) were adjusted for "been tattooed" (OR, 3.45; 95% CI, 0.64-21.32). # Risks involved two or more sex partners, a drug-using sex partner, or sex with a hepatitis case. No case reported dialysis/kidney transplantation, transfusion, acupuncture, sex with the same gender, sex with a transfusion recipient, or a history of sexually transmitted disease. * The crude OR and the adjusted matched OR (AOR) were calculated based on 176 observations because of missing values in some variables. † These procedures involved: 1) minimally invasive surgery, 2) admission to hospital for diagnosis or treatment of a medical condition without surgery, 3) an outpatient procedure, or 4) a dental procedure. ‡ Risks involved: 1) two or more sex partners, 2) a drug-using sex partner, or 3) sex with a hepatitis case.
the multivariate analysis, the most important predictor of HCV acquisition was high-risk sexual behavior (AOR, 13.0; 95% CI, 3.8-58.9) involving sex with two or more partners, with a drug-using partner, or with an individual who had hepatitis. In addition, a history of injecting drug use and tattooing were important. In fact, having been tattooed in the preceding 6 months was one of the strongest predictors in the univariate analysis (OR, 20.2; 95% CI, 3.7, infinity). This raises questions about the effectiveness of behavior-based deferral in Poland. We noted that, among our control group (which was expected to reflect the exposure experience of the Polish blood donor population), 16% reported such factors. Also of note was that, despite commonly unreported, deferrable behavioral risks, none of the respondents reported any major surgery or other deferrable medical exposure. The high prevalence of undisclosed behaviors may indicate low compliance with self-deferral based on behavioral criteria, which could stem from test-seeking behaviors. Another reason for noncompliance may be that donors self-assess their risk as very low and assume that the questions do not apply to them. 27 In contrast to this belief, our data indicate the importance of the contribution of such behaviors in the total burden of HCV WP infections in this population and, subsequently, most likely also in the residual risk resulting from the WP for NAT methods. Thus, improving adherence to deferral criteria seems to be the key to effectively tackling the problem of infections occurring in during the WP in Poland. Recent studies have indicated that multiple factors have a considerable impact on donors' compliance, such as their level of comprehension or acceptance and the simplicity of the predonation questionnaire and educational materials. [28] [29] [30] Donors also differ in behavioral attitudes and perceptions of certain risky behaviors. 31 Additional problems can also arise from the varying rates of those who present for donation mainly for the purpose of disease screening for their own information in different regions of the country. [12] [13] [14] [15] 32 Moreover, because test seekers are aware of their risks and know that a test for blood-borne infection would be indicated, 33 the testseeking behavior suggested by our study may indirectly point to deficiencies in the testing system, such as poor access and worse quality testing than are offered in other blood donation centers or other barriers. 34, 35 In Poland, for instance, free HCV screening is limited to pregnant women only. We also note that, during most of the studied period, more specific testing (e.g., recombinant immunoblot assay, NAT) was not routinely available in clinical laboratories. Therefore, the complete deferral of high-risk individuals cannot be achieved without increasing access to testing sites ideally equipped with state-of-the-art laboratory techniques. 15, 32 Finally, we observed that sexual practices contributed considerably to the total burden of HCV infection (almost 34% of cases) in the studied population, which was somewhat unexpected given the low efficiency of HCV transmission by sexual contact. 36 The most commonly reported high-risk sexual activity independently associated with newly acquired HCV infection was sex with multiple partners. Similarly to other authors, the significance of this predictor may be partially explained by its correlation with having a sexual partner who injects drugs. 37 High-risk sexual activities, such as sex with multiple partners, can frequently cluster with other risk factors, for example, alcohol or drug use. 38 Social factors, in particular the levels of socioeconomic status in which high-risk sexual behaviors tend to occur, also can play an even more important role. 39, 40 In our study, respondents who reported having sex with multiple partners also tended to report a history of arrests or detention (22% vs. 5%; p 5 0.017) and involvement in street fights in the preceding 6 months (17% vs. 2%; p 5 0.015). Both of these strongly predicted recent HCV acquisition in univariate analysis. Therefore, it is possible that the association of multiple partners with recent HCV infection is confounded by other "lifestyle" risks, some of which were ascertained in the questionnaire, but others possibly were not. Our findings may be limited due to ascertainment bias, because we were only able to include 30% of WP infections. The individual reasons for nonparticipation were not monitored. However, we need to highlight that a low ascertainment rate primarily results from the insufficient time available to medical staff to conduct full donors' postdonation risk-exposure assessment. Therefore, we are confident that the recruitment was nondifferential with respect to the exposures.
We also note that the survey contained questions on sensitive topics that could have been reported inaccurately (e.g., social desirability), especially because computerassisted or audio-assisted donor self-interviews were not available. Moreover, because these data were collected for informational purposes rather than to assess motivation for donating blood, we were unable to separate test seekers whose responses could have deviated from actual behaviors. In addition, due to the limited sample size, we were unable to assess whether the detected associations were stable over time. Even so, we observed that the detection rate of HCV WP donations remained stable, suggesting that the situation is unlikely to have changed substantially in this group. Finally, because of the inclusion criteria and recruitment of donors with documented HCV antibody seroconversion over the last 12 months, cases tended to be repeat donors (although HCV NAT-only-positive infections identified between 2002 and 2014 were also identified predominantly in repeat donors [77%]).
In conclusion, low compliance with donor deferral criteria for high-risk behaviors seems to be the main driving force of the high rate of WP donations in Poland. This study provides tangible evidence that donations that do not adhere to donor deferral criteria increase the residual risk of transfusion-related infections caused by WP infections and advocates against the liberalization of behaviorbased deferral policies in countries with concentrated HCV epidemics among particular subpopulations. Even given state-of-the-art laboratory techniques, deferral of subgroups at particular risk of infection remains one of the key components in ensuring blood safety. The current results also support the short temporal deferral of donors who undergo small medical procedures and dental treatments in Poland.
